Study of mutations in IDH1 and IDH2 genes in a sample of gliomas from Colombian population

Introduction: Gliomas are the most common primary tumors of the central nervous system and, according to their malignancy, they are graded from I to IV. Recent studies have found that there is an association between gliomas and mutations in exon 4 of genes that codify for isocitrate dehydrogenases 1...

Full description

Bibliographic Details
Main Authors: Orlando Ricaurte, Karina Neita, Danyela Valero, Jenny Ortega-Rojas, Carlos E. Arboleda-Bustos, Camilo Zubieta, José Penagos, Gonzalo Arboleda
Format: Article
Language:English
Published: Instituto Nacional de Salud 2018-05-01
Series:Biomédica: revista del Instituto Nacional de Salud
Subjects:
Online Access:https://www.revistabiomedica.org/index.php/biomedica/article/view/3708
_version_ 1818500046620983296
author Orlando Ricaurte
Karina Neita
Danyela Valero
Jenny Ortega-Rojas
Carlos E. Arboleda-Bustos
Camilo Zubieta
José Penagos
Gonzalo Arboleda
author_facet Orlando Ricaurte
Karina Neita
Danyela Valero
Jenny Ortega-Rojas
Carlos E. Arboleda-Bustos
Camilo Zubieta
José Penagos
Gonzalo Arboleda
author_sort Orlando Ricaurte
collection DOAJ
description Introduction: Gliomas are the most common primary tumors of the central nervous system and, according to their malignancy, they are graded from I to IV. Recent studies have found that there is an association between gliomas and mutations in exon 4 of genes that codify for isocitrate dehydrogenases 1 and 2 (IDH1: codon 132; IDH2: codon 172). Objective: To establish the frequency of mutations in IDH1 and IDH2 in a sample of gliomas from Colombian population. Materials and methods: DNA was extracted from tumor tissue. The exon 4 of IDH1 and IDH2 was amplified by PCR using specific primers and subsequently sequenced. Mutations were determined using the 4Peaks MAFFT programs. Results: We found mutations in the IDH1 gene in 34% of the glioma samples, with a predominance of the nonsynonymous mutation R132H. Mutations in the IDH2 gene were found in 7.5% of cases, with a predominance of the nonsynonymous R172K and R172W mutations. Conclusions: The frequency of mutations in the IDH1 and IDH2 genes in the sample was similar to that reported in other studies. The analysis of these mutations may be important to establish prognostic factors and for the development of future therapeutic targets in gliomas.
first_indexed 2024-12-10T20:37:44Z
format Article
id doaj.art-0007757794d842b49ab9c6b84ae9e4cf
institution Directory Open Access Journal
issn 0120-4157
0120-4157
language English
last_indexed 2024-12-10T20:37:44Z
publishDate 2018-05-01
publisher Instituto Nacional de Salud
record_format Article
series Biomédica: revista del Instituto Nacional de Salud
spelling doaj.art-0007757794d842b49ab9c6b84ae9e4cf2022-12-22T01:34:29ZengInstituto Nacional de SaludBiomédica: revista del Instituto Nacional de Salud0120-41570120-41572018-05-01380869210.7705/biomedica.v38i0.37082096Study of mutations in IDH1 and IDH2 genes in a sample of gliomas from Colombian populationOrlando Ricaurte0Karina Neita1Danyela Valero2Jenny Ortega-Rojas3Carlos E. Arboleda-Bustos4Camilo Zubieta5José Penagos6Gonzalo Arboleda7Grupo de Patología Molecular, Facultad de Medicina, Universidad Nacional de Colombia, Bogotá, D.C., ColombiaGrupo de Neurociencias y Muerte Celular, Instituto de Genética, Facultad de Medicina, Universidad Nacional de Colombia, Bogotá, D.C., ColombiaGrupo de Neurociencias y Muerte Celular, Instituto de Genética, Facultad de Medicina, Universidad Nacional de Colombia, Bogotá, D.C., ColombiaGrupo de Neurociencias y Muerte Celular, Instituto de Genética, Facultad de Medicina, Universidad Nacional de Colombia, Bogotá, D.C., ColombiaGrupo de Neurociencias y Muerte Celular, Instituto de Genética, Facultad de Medicina, Universidad Nacional de Colombia, Bogotá, D.C., ColombiaGrupo de Neurocirugía, Instituto Nacional de Cancerología, Bogotá, D.C., ColombiaGrupo de Neurocirugía, Instituto Nacional de Cancerología, Bogotá, D.C., ColombiaGrupo de Patología Molecular, Facultad de Medicina, Universidad Nacional de Colombia, Bogotá, D.C., Colombia Grupo de Neurociencias y Muerte Celular, Instituto de Genética, Facultad de Medicina, Universidad Nacional de Colombia, Bogotá, D.C., ColombiaIntroduction: Gliomas are the most common primary tumors of the central nervous system and, according to their malignancy, they are graded from I to IV. Recent studies have found that there is an association between gliomas and mutations in exon 4 of genes that codify for isocitrate dehydrogenases 1 and 2 (IDH1: codon 132; IDH2: codon 172). Objective: To establish the frequency of mutations in IDH1 and IDH2 in a sample of gliomas from Colombian population. Materials and methods: DNA was extracted from tumor tissue. The exon 4 of IDH1 and IDH2 was amplified by PCR using specific primers and subsequently sequenced. Mutations were determined using the 4Peaks MAFFT programs. Results: We found mutations in the IDH1 gene in 34% of the glioma samples, with a predominance of the nonsynonymous mutation R132H. Mutations in the IDH2 gene were found in 7.5% of cases, with a predominance of the nonsynonymous R172K and R172W mutations. Conclusions: The frequency of mutations in the IDH1 and IDH2 genes in the sample was similar to that reported in other studies. The analysis of these mutations may be important to establish prognostic factors and for the development of future therapeutic targets in gliomas.https://www.revistabiomedica.org/index.php/biomedica/article/view/3708sistema nervioso centralgliomaADN de neoplasiasColombia
spellingShingle Orlando Ricaurte
Karina Neita
Danyela Valero
Jenny Ortega-Rojas
Carlos E. Arboleda-Bustos
Camilo Zubieta
José Penagos
Gonzalo Arboleda
Study of mutations in IDH1 and IDH2 genes in a sample of gliomas from Colombian population
Biomédica: revista del Instituto Nacional de Salud
sistema nervioso central
glioma
ADN de neoplasias
Colombia
title Study of mutations in IDH1 and IDH2 genes in a sample of gliomas from Colombian population
title_full Study of mutations in IDH1 and IDH2 genes in a sample of gliomas from Colombian population
title_fullStr Study of mutations in IDH1 and IDH2 genes in a sample of gliomas from Colombian population
title_full_unstemmed Study of mutations in IDH1 and IDH2 genes in a sample of gliomas from Colombian population
title_short Study of mutations in IDH1 and IDH2 genes in a sample of gliomas from Colombian population
title_sort study of mutations in idh1 and idh2 genes in a sample of gliomas from colombian population
topic sistema nervioso central
glioma
ADN de neoplasias
Colombia
url https://www.revistabiomedica.org/index.php/biomedica/article/view/3708
work_keys_str_mv AT orlandoricaurte studyofmutationsinidh1andidh2genesinasampleofgliomasfromcolombianpopulation
AT karinaneita studyofmutationsinidh1andidh2genesinasampleofgliomasfromcolombianpopulation
AT danyelavalero studyofmutationsinidh1andidh2genesinasampleofgliomasfromcolombianpopulation
AT jennyortegarojas studyofmutationsinidh1andidh2genesinasampleofgliomasfromcolombianpopulation
AT carlosearboledabustos studyofmutationsinidh1andidh2genesinasampleofgliomasfromcolombianpopulation
AT camilozubieta studyofmutationsinidh1andidh2genesinasampleofgliomasfromcolombianpopulation
AT josepenagos studyofmutationsinidh1andidh2genesinasampleofgliomasfromcolombianpopulation
AT gonzaloarboleda studyofmutationsinidh1andidh2genesinasampleofgliomasfromcolombianpopulation